X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (39) 39
hiv (36) 36
humans (34) 34
adult (30) 30
male (29) 29
hiv infections - drug therapy (28) 28
female (25) 25
infectious diseases (24) 24
antiretroviral therapy (23) 23
human immunodeficiency virus--hiv (22) 22
immunology (19) 19
middle aged (18) 18
asia (17) 17
acquired immune deficiency syndrome--aids (15) 15
anti-hiv agents - therapeutic use (15) 15
aids/hiv (13) 13
mortality (13) 13
drug therapy (12) 12
hiv infections - complications (12) 12
patients (12) 12
risk factors (12) 12
hiv infection (11) 11
medicine (11) 11
research (11) 11
research article (11) 11
antiretroviral agents (10) 10
cd4 lymphocyte count (10) 10
virology (10) 10
aids (9) 9
antiretroviral drugs (9) 9
antiviral agents (9) 9
hiv infections - virology (9) 9
regression analysis (9) 9
tuberculosis (9) 9
viral load (9) 9
young adult (9) 9
adults (8) 8
cohort (8) 8
hepatitis c (8) 8
hiv patients (8) 8
hospitals (8) 8
prospective studies (8) 8
cd4 antigen (7) 7
hiv infections - immunology (7) 7
therapy (7) 7
active antiretroviral therapy (6) 6
aids-related opportunistic infections - drug therapy (6) 6
analysis (6) 6
antiretroviral therapy, highly active (6) 6
data bases (6) 6
hepatitis (6) 6
hepatitis c virus (6) 6
human immunodeficiency virus (6) 6
indonesia (6) 6
infections (6) 6
microbiology (6) 6
treatment outcome (6) 6
virological failure (6) 6
acquired immune deficiency syndrome (5) 5
adolescent (5) 5
anti-retroviral agents - therapeutic use (5) 5
article (5) 5
asia - epidemiology (5) 5
base-line (5) 5
databases (5) 5
dosage and administration (5) 5
drugs (5) 5
epidemiology (5) 5
follow-up (5) 5
highly active antiretroviral therapy (5) 5
hiv infections - epidemiology (5) 5
individuals (5) 5
infected patients (5) 5
patient outcomes (5) 5
prevalence (5) 5
public, environmental & occupational health (5) 5
risk analysis (5) 5
risk-factors (5) 5
statistical analysis (5) 5
anti-hiv agents - administration & dosage (4) 4
biology and life sciences (4) 4
care and treatment (4) 4
chronic hepatitis-c (4) 4
cohort studies (4) 4
coinfected patients (4) 4
coinfection (4) 4
collaboration (4) 4
data collection (4) 4
databases, factual (4) 4
diagnosis (4) 4
drug therapy, combination (4) 4
health aspects (4) 4
hepatitis c - complications (4) 4
hiv-1 (4) 4
infection (4) 4
lymphocytes (4) 4
medicine and health sciences (4) 4
multidisciplinary sciences (4) 4
prevention (4) 4
proportional hazards models (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Acta medica Indonesiana, ISSN 0125-9326, 01/2016, Volume 48, Issue 1, pp. 1 - 2
Antiretroviral is one of the drugs that extensively been studied for its drug-to- drug interaction. Its long term used and the fact that many HIV-infected... 
Anti-HIV Agents - administration & dosage | Benzoxazines - administration & dosage | Anti-HIV Agents - adverse effects | Humans | Central Nervous System - drug effects | Benzoxazines - adverse effects | HIV Infections - drug therapy
Journal Article
Advanced Science Letters, ISSN 1936-6612, 07/2017, Volume 23, Issue 7, pp. 6896 - 6898
Introduction: Despite being one of five medicines commonly prescribed in the United States, PPI use is deemed controversial for patients with cirrhosis. The... 
SBP | PPI | Liver Cirrhosis | Ascites | EBCR | Patients
Journal Article
CURRENT HIV RESEARCH, ISSN 1570-162X, 2019, Volume 17, Issue 3, pp. 204 - 213
Journal Article
Journal Article
Medical mycology, ISSN 1369-3786, 09/2019
We performed morphology, molecular study and antifungal susceptibility test on 10 Talaromyces sp. isolates: eight clinical isolates (human immunodeficiency... 
Journal Article
Acta Medica Indonesiana, ISSN 0125-9326, 11/2019, Volume 51, Issue 3
This is the first report of HIV drug resistance in RSUPN Dr. Cipto Mangunkusumo. We tested We reviewed eleven new cases of HIV patients who had virologic... 
virologic failure | hiv-1 | hiv drug resistance
Journal Article
PLoS ONE, ISSN 1932-6203, 03/2016, Volume 11, Issue 3, p. e0150512
Background We assessed the effects of hepatitis B (HBV) or hepatitis C (HCV) co-infection on outcomes of antiretroviral therapy (ART) in HIV-infected patients... 
MORTALITY | DRUG-USERS | IMPACT | METAANALYSIS | IMMUNODEFICIENCY-VIRUS-INFECTION | MULTIDISCIPLINARY SCIENCES | ANTIRETROVIRAL THERAPY | IMMUNE RECOVERY | COHORT | LIVER-DISEASE | PROGRESSION | Anti-Retroviral Agents - therapeutic use | HIV-1 - drug effects | HIV Infections - epidemiology | Humans | Middle Aged | Risk Factors | Hepatitis B - epidemiology | Male | Treatment Outcome | CD4 Lymphocyte Count | Coinfection - epidemiology | Coinfection - complications | Antiretroviral Therapy, Highly Active | Hepatitis B - complications | Asia - epidemiology | HIV-1 - isolation & purification | Hepatitis C - epidemiology | HIV Infections - complications | Survival Analysis | Adult | Female | HIV Infections - drug therapy | Hepatitis C - complications | Cohort Studies | Patient outcomes | HIV patients | Research | Hepatitis C | HIV infection | Health aspects | Risk factors | Hepatitis B | Health sciences | Infections | Multivariate analysis | Recovery | Data bases | Hepatitis | Regression models | Databases | Immunology | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Hepatitis B virus | Drug therapy | Age | Antiretroviral drugs | Medical research | Immune response | Hepatitis B surface antigen | Mortality | Test procedures | Health risks | Regression analysis | Risk analysis | Ribonucleic acid--RNA | Patients | Survival | Community colleges | Antiretroviral therapy | CD4 antigen | Medicine | Survival analysis | Hospitals | Infectious diseases | Hepatitis C virus | RNA | Acquired immune deficiency syndrome | Ribonucleic acid | AIDS | HIV | Human immunodeficiency virus
Journal Article
Annals of Epidemiology, ISSN 1047-2797, 2013, Volume 23, Issue 11, pp. 720 - 723
Journal Article
Antiviral therapy, 2019, Volume 24, Issue 4, p. 271
We aimed to project the 10-year future incidence of cardiovascular disease (CVD) and model several intervention scenarios based on a multi-site Asian... 
Journal Article
JAIDS Journal of Acquired Immune Deficiency Syndromes, ISSN 1525-4135, 04/2019, Volume 80, Issue 4, pp. 436 - 443
BACKGROUND:Mycobacterium avium complex prophylaxis is recommended for patients with advanced HIV infection. With the decrease in incidence of disseminated... 
mortality | macrolide prophylaxis | AIDS-defining conditions | Mycobacterium avium complex | HIV | INFECTIOUS DISEASES | INFECTIONS | PNEUMOCYSTIS-CARINII-PNEUMONIA | PREVENTION | FOLLOW-UP | ANTIRETROVIRAL THERAPY | IMMUNOLOGY | MYCOBACTERIUM-AVIUM COMPLEX | ERA | PREDICTORS | WEEKLY AZITHROMYCIN | OPPORTUNISTIC ILLNESSES | Humans | Middle Aged | Mycobacterium avium-intracellulare Infection - prevention & control | AIDS-Related Opportunistic Infections - drug therapy | Antibiotic Prophylaxis - methods | Male | CD4 Lymphocyte Count | Acquired Immunodeficiency Syndrome - drug therapy | Young Adult | Anti-Bacterial Agents - therapeutic use | AIDS-Related Opportunistic Infections - prevention & control | Mycobacterium avium Complex - drug effects | Mycobacterium avium-intracellulare Infection - drug therapy | AIDS-Related Opportunistic Infections - mortality | Acquired Immunodeficiency Syndrome - pathology | Adult | Female | Macrolides - therapeutic use | Antiretroviral drugs | Therapy | Sensitivity analysis | Statistical analysis | Cell survival | Mortality | Prophylaxis | Health risks | Infections | Regression analysis | Risk analysis | Antiretroviral therapy | CD4 antigen | Confidence intervals | Data transfer (computers) | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2014, Volume 9, Issue 9, p. e106525
Journal Article
Journal Article
Pharmacoepidemiology and Drug Safety, ISSN 1053-8569, 11/2018, Volume 27, Issue 11, pp. 1209 - 1216
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2013, Volume 8, Issue 6, p. e64902
Journal Article
by Tanuma, Junko and Jiamsakul, Awachana and Makane, Abhimanyu and Avihingsanon, Anchalee and Ng, Oon Tek and Kiertiburanakul, Sasisopin and Chaiwarith, Romanee and Kumarasamy, Nagalingeswaran and Van Nguyen, Kinh and Pham, Thuy Thanh and Lee, Man Po and Ditangco, Rossana and Merati, Tuti Parwati and Choi, Jun Yong and Wong, Wing Wai and Kamarulzaman, Adeeba and Yunihastuti, Evy and Sim, Benedict Lh and Ratanasuwan, Winai and Kantipong, Pacharee and Zhang, Fujie and Mustafa, Mahiran and Saphonn, Vonthanak and Pujari, Sanjay and Sohn, Annette H and Mean, C.V and Saphonn, V and Vohith, K and Zhang, F.J and Zhao, H.X and Han, N and Li, P.C.K and Lam, W and Chan, Y.T and Wong, K.H and Saghayam, S and Ezhilarasi, C and Joshi, K and Wirawan, D.N and Yuliana, F and Imran, D and Widhani, A and Oka, S and Nishijima, T and Na, S and Kim, J.M and Gani, Y.M and David, R and Omar, S.F. Syed and Ponnampalavanar, S and Azwa, I and Huda, N and Ong, L.Y and Uy, E and Bantique, R and Ku, W.W and Wu, P.C and Lim, P.L and Lee, L.S and Ohnmar, P.S and Phanuphak, P and Ruxrungtham, K and Chusut, P and Sirivichayakul, S and Sungkanuparph, S and Chumla, L and Sanmeema, N and Chaiwarith, R and Sirisanthana, T and Kotarathititum, W and Praparattanapan, J and Kantipong, P and Kambua, P and Sriondee, R and Bui, V.H and Cao, T.T and Cuong, D.D and Ha, H.L and Durier, N and Petersen, B and Singtoroj, T and Cooper, D.A and Law, M.G and Boettiger, D.C and TAHOD and TREAT Asia HIV Observational Databases (TAHOD)
PLoS ONE, ISSN 1932-6203, 08/2016, Volume 11, Issue 8, pp. e0161562 - e0161562
Background In resource-limited settings, routine monitoring of renal function during antiretroviral therapy (ART) has not been recommended. However, concerns... 
BASE-LINE | RISK-FACTORS | MULTIDISCIPLINARY SCIENCES | DISOPROXIL FUMARATE | INCOMPLETE REVERSIBILITY | ANTIRETROVIRAL THERAPY | DEATH | CHRONIC KIDNEY-DISEASE | ASSOCIATION | EXPOSURE | DECLINE | Glomerular Filtration Rate | Kidney - drug effects | Prospective Studies | Tenofovir - adverse effects | Tenofovir - therapeutic use | Anti-HIV Agents - adverse effects | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Male | Kidney Diseases - chemically induced | Creatinine - blood | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Poisson Distribution | Kidney - physiopathology | Databases, Factual | Tenofovir | Complications and side effects | Chronic kidney failure | Patient outcomes | Dosage and administration | Research | Drug therapy | HIV infection | Risk factors | Health sciences | Renal function | Epidemiology | Incidence | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Blood pressure | Poisson density functions | Monitoring | Chronic illnesses | Creatinine | Hypertension | Antiretroviral drugs | Statistical analysis | Epidermal growth factor receptors | Mortality | Risk analysis | Patients | Antiretroviral therapy | Glomerular filtration rate | Medicine | Infectious diseases | Hospitals | Kidney diseases | Index Medicus | Acquired immune deficiency syndrome | AIDS | HIV | Human immunodeficiency virus
Journal Article